print page Print
pamela-paley-md

Pamela J. Paley, MD

Gynecologic Oncology
Accepting New Patients
(425) 635-3400 Offers Virtual Visits

About Me

Specialties
  • Gynecologic Oncology
Languages
  • English
Clinical Interests
  • Women with ovarian, endometrial, cervical and other other gynecologic cancers
  • Risk-reducing strategies for women with an inherited susceptibility for breast and ovarian cancer and other gynecologic cancers
  • Complex gynecologic surgery for non-cancerous conditions

Where to Find Pamela J. Paley, MD

Education

Medical Education
Loyola University of Chicago - Stritch School of Medicine (1990)
Maywood, IL
Internship
Duke University
Durham, NC
Residency
Duke University
Durham, NC
Fellowship
University of Minnesota
Specialty: Gynecologic Oncology
Minneapolis, MN

Board Certification

American Board of Obstetrics & Gynecology Subspecialty: Gynecologic Oncology

Highlights

Awards
Top Doctors (2008, 2009, 2013, 2015, 2016, 2017, 2018, 2019, 2020, 2021)
Seattle Magazine
Top Doctors (2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021)
Seattle Met

Publications & Media

International Journal of Gynecological Cancer • August 2021 Continuing medical education during COVID-19: virtual training for gynecologic oncology management in Rwanda
Healthgrades • August 13, 2020 Women’s Care: Leading Voices from the Front Lines
Health Psychology • January 2019 False-positive screening events and worry influence decisions about surgery among high-risk women
Journal of Gynecologic Oncology • November 2017 Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer
American Journal of Obstetrics & Gynecology • July 2016 A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging
Cancer Epidemiology, Biomarkers & Prevention • July 2014 Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women
Cancer Epidemiology, Biomarkers & Prevention • November 2012 Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer
Cancer (American Cancer Society Journal) • August 2011 Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study
Journal of Gynecologic Oncology • August 2011 Patterns of spread and recurrence of sex cord-stromal tumors of the ovary
American Journal of Obstetrics & Gynecology • June 2011 Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases
Journal of Gynecologic Oncology • March 2011 Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
Journal of Gynecologic Oncology • August 2009 The temporal stability of the Symptom Index among women at high-risk for ovarian cancer
Cancer Epidemiology, Biomarkers & Prevention • May 2009 Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125
Cancer Epidemiology, Biomarkers & Prevention • September 2008 Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer
The Cancer Journal • August 2008 Combining a symptoms index with CA 125 to improve detection of ovarian cancer
American Journal of Obstetrics & Gynecology • June 2008 Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging
Journal of Gynecologic Oncology • December 2006 Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis
American Journal of Obstetrics & Gynecology • June 2006 Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy
Journal of Gynecologic Oncology • October 2004 A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy
Journal of Gynecologic Oncology • July 2003 The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer
International Journal of Cancer • March 2003 Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q
Journal of Gynecologic Oncology • January 2003 Evaluation of p27 in preinvasive and invasive malignancies of the cervix
Journal of Gynecologic Oncology • October 2002 Pathologic findings in prophylactic oophorectomy specimens in high-risk women
Journal of Gynecologic Oncology • May 2002 Glassy cell carcinoma of the cervix revisited
Current Oncology Reports • March 2002 Angiogenesis in ovarian cancer: molecular pathology and therapeutic strategies
Current Opinion in Oncology • September 2001 Ovarian cancer screening: are we making any progress?
Gene Journal • April 2001 MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily
American Journal of Obstetrics & Gynecology • April 2001 Screening for the major malignancies affecting women: current guidelines
Journal of Gynecologic Oncology • April 2001 Evaluation of chemoresistance markers in women with epithelial ovarian carcinoma
Journal of Gynecologic Oncology • February 2001 Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis
Journal of Gynecologic Oncology • September 2000 Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer
Obstetrics and Gynecology Journal • June 2000 Leydig cell tumor, mature teratoma, and nongestational choriocarcinoma in a single ovary
Journal of Gynecologic Oncology • March 2000 The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma
Journal of Gynecologic Oncology • November 1999 Pretreatment scalene node biopsy in gynecologic malignancy: prudent or passé?
Journal of Gynecologic Oncology • September 1999 Impact of surgical staging in women with locally advanced cervical cancer
Journal of Gynecologic Oncology • April 1999 A new technique for performing Syed template interstitial implants for anterior vaginal tumors using an open retropubic approach
The Cancer Journal • June 1998 Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking
Journal of Gynecologic Oncology • November 1997 Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer
The Cancer Journal • July 1997 Vascular endothelial growth factor expression in early stage ovarian carcinoma
Journal of Gynecologic Oncology • March 1997 A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch)
Journal of Gynecologic Oncology • February 1997 The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy